A new guideline on menopause and perimenopause management has been released. The guideline may involve changes to hormone replacement therapy, with some reports indicating that warning labels on hormone-based menopause drugs will be removed. The development is part of broader efforts to address menopause management, with various organizations and governments issuing their own guidelines and statements on the topic.